Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 54-59 , April 2010

Carbon ion radiation therapy for high-risk meningiomas

  • Stephanie E. Combs

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany
    • Corresponding Author InformationCorresponding author. Address: Neuro-Radiation Oncology Research Group, Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
  • ,
  • Christian Hartmann

      Affiliations

    • Department of Neuropathology, University Hospital of Heidelberg, Heidelberg, Germany
    • Clinical Cooperation Unit Neuro-Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • ,
  • Anna Nikoghosyan

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany
  • ,
  • Oliver Jäkel

      Affiliations

    • Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
    • Heidelberger Ionenstrahl Therapiezentrum (HIT), Heidelberg, Germany
  • ,
  • Christian P. Karger

      Affiliations

    • Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • ,
  • Thomas Haberer

      Affiliations

    • Heidelberger Ionenstrahl Therapiezentrum (HIT), Heidelberg, Germany
  • ,
  • Andreas von Deimling

      Affiliations

    • Department of Neuropathology, University Hospital of Heidelberg, Heidelberg, Germany
    • Clinical Cooperation Unit Neuro-Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
  • ,
  • Marc W. Münter

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
  • ,
  • Peter E. Huber

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • German Cancer Research Center (DKFZ), Clinical Cooperation Unit Radiation Oncology, Heidelberg, Germany
  • ,
  • Jürgen Debus

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • Heidelberger Ionenstrahl Therapiezentrum (HIT), Heidelberg, Germany
  • ,
  • Daniela Schulz-Ertner

      Affiliations

    • Department of Radiation Oncology, University Hospital of Heidelberg, Heidelberg, Germany
    • Radiological Institute (MVZ), Markus Hospital, 60431 Frankfurt, Germany

Received 25 October 2009 ,Revised 22 December 2009 ,Accepted 22 December 2009.

References 

  1. Bondy M, Ligon BL. Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol. 1996;29:197–205
  2. Palma L, Celli P, Franco C, Cervoni L, Cantore G. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. Neurosurg Focus. 1997;2:e3
  3. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20:22–39
  4. Mahmood A, Qureshi NH, Malik GM. Intracranial meningiomas: analysis of recurrence after surgical treatment. Acta Neurochir (Wien). 1994;126:53–58
  5. Debus J, Wuendrich M, Pirzkall A, Hoess A, Schlegel W, Zuna I, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol. 2001;19:3547–3553
  6. Maier H, Ofner D, Hittmair A, Kitz K, Budka H. Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg. 1992;77:616–623
  7. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997;21:1455–1465
  8. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3:255–268
  9. Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ. Radiotherapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys. 1996;34:817–822
  10. Austin-Seymour M, Munzenrider J, Linggood R, Goitein M, Verhey L, Urie M, et al. Fractionated proton radiation therapy of cranial and intracranial tumors. Am J Clin Oncol. 1990;13:327–330
  11. Miralbell R, Linggood RM, De La MS, Convery K, Munzenrider JE, Mirimanoff RO. The role of radiotherapy in the treatment of subtotally resected benign meningiomas. J Neurooncol. 1992;13:157–164
  12. Gudjonsson O, Blomquist E, Nyberg G, Pellettieri L, Montelius A, Grusell E, et al. Stereotactic irradiation of skull base meningiomas with high energy protons. Acta Neurochir (Wien). 1999;141:933–940
  13. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, et al. Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol. 2000;48:151–160
  14. Miralbell R, Cella L, Weber D, Lomax A. Optimizing radiotherapy of orbital and paraorbital tumors: intensity-modulated X-ray beams vs. intensity-modulated proton beams. Int J Radiat Oncol Biol Phys. 2000;47:1111–1119
  15. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La MS, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1363–1370
  16. Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys. 2001;49:99–105
  17. Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol. 2004;71:251–258
  18. Noel G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys. 2005;62:1412–14122
  19. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol. 2007;25:953–964
  20. Schulz-Ertner D, Nikoghosyan A, Thilmann C, Haberer T, Jakel O, Karger C, et al. Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys. 2004;58:631–640
  21. Kleihues P, Cavenee WK. Pathology and genetics of tumours of the central nervous system. 2nd ed.. Lyon: IARC Press; 2000;
  22. Louis DN. International Agency for Research on Cancer. WHO classification of tumours of the central nervous system. Lyon: International Agency for Research on Cancer; 2007.
  23. Schlegel W, Pastyr O, Bortfeld T, Gademann G, Menke M, Maier-Borst W. Stereotactically guided fractionated radiotherapy: technical aspects. Radiother Oncol. 1993;29:197–204
  24. Schulz-Ertner D, Karger CP, Feuerhake A, Nikoghosyan A, Combs SE, Jakel O, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys. 2007;68:449–457
  25. Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, Jakel O, et al. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007;67:171–177
  26. Keller-Reichenbecher MA, Bortfeld T, Levegrun S, Stein J, Preiser K, Schlegel W. Intensity modulation with the “step and shoot” technique using a commercial MLC: a planning study. Multileaf collimator. Int J Radiat Oncol Biol Phys. 1999;45:1315–1324
  27. Milker-Zabel S, Zabel-du BA, Huber P, Schlegel W, Debus J. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys. 2007;68:858–863
  28. Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res. 1993;A330:296–305
  29. Scholz M, Kellerer AM, Kraft-Weyrather W, Kraft G. Computation of cell survival in heavy ion beams for therapy. The model and its approximation. Radiat Environ Biophys. 1997;36:59–66
  30. Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat. 2003;2:427–436
  31. Kramer M, Jakel O, Haberer T, Rietzel E, Schardt D, Scholz M, et al. Treatment planning for scanned ion beams. Radiother Oncol. 2004;73:S80–S85
  32. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival analysis part I: basic concepts and first analyses. Br J Cancer. 2003;89:232–238
  33. Goyal LK, Suh JH, Mohan DS, Prayson RA, Lee J, Barnett GH. Local control and overall survival in atypical meningioma: a retrospective study. Int J Radiat Oncol Biol Phys. 2000;46:57–61
  34. Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M, et al. Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the rare cancer network. Int J Radiat Oncol Biol Phys. 2008;71:1388–13893
  35. Engenhart-Cabillic R, Farhoud A, Sure U, Heinze S, Henzel M, Mennel HD, et al. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlenther Onkol. 2006;182:641–646
  36. Condra KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB, Rhoton AL. Benign meningiomas: primary treatment selection affects survival. Int J Radiat Oncol Biol Phys. 1997;39:427–436
  37. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg. 1985;62:18–24
  38. Yamashita J, Handa H, Iwaki K, Abe M. Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg Neurol. 1980;14:33–40
  39. Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys. 1990;18:755–761
  40. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg. 1994;80:195–201
  41. Pourel N, Auque J, Bracard S, Hoffstetter S, Luporsi E, Vignaud JM, et al. Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience. Radiother Oncol. 2001;61:65–70
  42. Cozzi L, Fogliata A, Lomax A, Bolsi A. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. Radiother Oncol. 2001;61:287–297
  43. Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys. 2003;55:785–792
  44. Feltz R, Schalldach U, Kruger J, Ruhashya R. Malignant brain tumors after radiation – glioblastomas after operation and radiation of meningiomas – 2 case reports. Zentralbl Neurochir. 2001;62:48–56
  45. Yu JS, Yong WH, Wilson D, Black KL. Glioblastoma induction after radiosurgery for meningioma. Lancet. 2000;356:1576–1577
  46. Boskos C, Feuvret L, Noel G, Habrand JL, Pommier P, Alapetite C, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys. 2009;75:399–406
  47. Cushing HW, Eisenhardt L. Meningiomas: their classification, regional behaviour, life histolgy, and surgical end results. Springfield, Illinois: Charles C.Thomas; 1938;
  48. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. Berlin: Springer; 1993;
  49. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999;85:2046–2056
  50. Simon M, Bostrom J, Koch P, Schramm J. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg.Psychiatry. 2006;77:767–773

PII: S0167-8140(10)00006-X

doi: 10.1016/j.radonc.2009.12.029

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 54-59 , April 2010